The Warburg effect in cancer cells has been proposed to involve several mechanisms, including adaptation to hypoxia, oncogenes activation or loss of oncosuppressors and impaired mitochondrial function. In previous papers, it has been shown that K-ras transformed mouse cells are much more sensitive as compared with normal cells to glucose withdrawal (undergoing apoptosis) and present a high glycolytic rate and a strong reduction of mitochondrial complex I. Recent observations suggest that transformed cells have a derangement in the cyclic adenosine monophosphate/cAMP-dependent protein kinase (cAMP/PKA) pathway, which is known to regulate several mitochondrial functions. Herein, the derangement of the cAMP/PKA pathway and its impact on transformation-linked changes of mitochondrial functions is investigated. Exogenous stimulation of PKA activity, achieved by forskolin treatment, protected K-ras-transformed cells from apoptosis induced by glucose deprivation, enhanced complex I activity, intracellular adenosine triphosphate (ATP) levels, mitochondrial fusion and decreased intracellular reactive oxygen species (ROS) levels. Several of these effects were almost completely prevented by inhibiting the PKA activity. Short-time treatment with compounds favoring mitochondrial fusion strongly decreased the cellular ROS levels especially in transformed cells. These findings support the notion that glucose shortage-induced apoptosis, specific of K-ras-transformed cells, is associated to a derangement of PKA signaling that leads to mitochondrial complex I decrease, reduction of ATP formation, prevalence of mitochondrial fission over fusion, and thereby opening new approaches for development of anticancer drugs.
INTRODUCTION
Tumors are generally characterized by a high rate of anaerobic and aerobic glycolysis and a reduced rate of respiration. 1 --6 This switch of energy metabolism is known as the 'Warburg effect' and it has been reported to be linked to mitochondrial dysfunctions that lead cells to depend on glycolysis to generate adenosine triphosphate (ATP). 7 --9 The genetic and phenotypic features involved in this general derangement of cellular energy metabolism in tumors are not yet fully understood. 3, 5 However, there are several evidences that alterations in signaling pathways, which regulate glucose uptake and utilization and mitochondrial functions, may contribute to the Warburg effect. 10 --13 In addition, cancer cells mitochondria have been reported to be associated with mitochondrial DNA mutations, 14, 15 altered expression of mitochondrial enzymes, 16 reduced levels and activity of mitochondrial OXPHOS complexes 17 --19 and deregulation of mitochondrial fusion and fission. 20 In various human tumors (up to 35%), the oncogenic ras gene has been found mutated 21, 22 and these mutations have a critical role in the onset of different malignant phenotypes. The ras genes encode for guanidine nucleotide binding proteins that mediate cellular signal transduction pathways controlling cell growth and differentiation. 21, 22 Although active form of the ras family members, such as K-ras, have been related to enhancement of intracellular level of cyclic adenosine monophosphate (cAMP), through activation of the plasma membrane adenylyl cyclase, 23 --25 a depression of genes encoding for components of the cyclic adenosine monophosphate/cAMP-dependent protein kinase (cAMP/PKA) signaling pathway has also been reported. 10,26 --31 The cAMP/PKA pathway is known to regulate cellular energy metabolism, exerting a stimulatory effect on glucose transport and utilization, 32 --34 glycolysis, glycogen breakdown and glucose oxidation. 35 The cAMP/PKA pathway has recently been found to regulate also mitochondrial respiration, 36 --39 dynamics 40, 41 and apoptosis. 42, 43 Proteins belonging to the cAMP/PKA pathway are associated with various cellular compartments and structures 44 including the outer membrane 45 and the inner compartment of mitochondria. 46 --49 The cytosolic pool of cAMP, produced by the plasma membrane adenylyl cyclase, enhances the functional capacity of complex I (NADH-ubiquinone oxidoreductase) of the respiratory chain and reduces reactive oxygen species (ROS) production through activation of PKA. 37, 50 In recent years, an in vitro model of cellular transformation has been developed. It is represented by two NIH3T3 derived stable cell lines, NIH3T3 cells expressing an oncogenic K-ras (transformed cell line) and NIH-ras cells expressing a GEF-DN, a protein able to downregulate ras activation and to phenotipically revert transformed cells (reverted cell line). 13 ,51 K-ras cell line has been extensively characterized and found to have several metabolic alterations. 13, 52, 53 It has been shown that the enhanced proliferation potential of K-ras-transformed cells requires high initial glucose and glutamine concentrations in the medium.
The selective growth advantage of transformed cells is lost in sub-optimal glucose or glutamine growth conditions. Glucose and glutamine-dependent growth correlates with an altered metabolic pattern namely increased glucose utilization and lactate production, increased utilization of glutamine through the tricarboxylic acid cycle, increased expression of glycolytic genes, depressed expression of mitochondrial genes, altered mitochondrial morphology and reduced ability of ATP production. 13, 52, 54 Transformed cells produce large amount of ROS associated with decreased activity of mitochondrial complex I 55 and increased cell death. 13 Remarkably, several metabolic phenotypes induced by oncogenic K-ras expression are almost completely reverted by the GEF-DN expression 52 --54 suggesting a main role of oncogenic ras signaling in the induction and maintenance of metabolic alterations.
This study was aimed at examining alterations of the cAMP/PKA pathway in K-ras-transformed murine NIH3T3 fibroblasts and human breast cancer MDA-MB-231 cells and their impact on cell growth and energy metabolism.
The results show that in both cell lines there is an alteration of the cAMP/PKA system, characterized by enhanced excitability of the plasma membrane adenylyl cyclase but a reduced PKA activity. This alteration of the cAMP/PKA pathway in oncogenic K-ras cells was associated with a shift of mitochondrial dynamics to a more fragmented structure, increased apoptosis under glucose deprivation, deficiency of complex I activity and ATP production and increase in intracellular ROS levels. Forskolin (FSK), a known activator of adenylyl cyclase, leading to an increase in the cytosolic level of cAMP and hence to PKA activation, induced a reversion of all these changes and promoted survival of oncogenic K-ras cells.
RESULTS
K-ras transformation induces marked glucose dependence of cell growth NIH3T3 cells are a genetically well-characterized immortalized cell line that has long been established as a model of 'normal' cells for the study of cell transformation, as these cells undergo contact inhibition, exhibit no growth in soft agar and do not form tumors in immunocompromised mice, 56 in contrast to isogenic transformed lines as K-ras NIH3T3 cells. 51 Besides, as previously described, oncogenic ras proteins expression correlates with the appearance of several characteristic metabolic alterations of cancer cells. 13,21,57 --59 Given that both Ras and cAMP/PKA pathways are able to control cellular metabolism and proliferation, 60 we decided to test the relationship between the cAMP/PKA system and the proliferation ability of NIH3T3 and K-ras NIH3T3 cells on alteration of glucose availability.
Asynchronous NIH3T3 (normal) and K-ras NIH3T3 (transformed) cell lines were cultured in normal growth medium (25 mM glucose), in a low glucose medium (1 mM glucose), in glucosefree medium supplemented with 25 mM galactose, an obligate mitochondrial oxidative substrate, or in 5 mM fructose. The growth of normal cells declined after 72 h in both 25 and 1 mM glucose and at 48 h in galactose (Figures 1a and c) and fructose (Supplementary Figure S1A) . Transformed cells maintained a vigorous growth for at least 96 h in 25 mM glucose but lost their proliferative ability in 1 mM glucose (Figure 1b Figure  S1B) . Addition to the culture medium of oligomycin (OM) (Figure 1d ), a specific inhibitor of the mitochondrial F o F 1 ATP synthase, 61 in normal cells reduced the ATP levels by around 30% both at 25 and 1 mM glucose. Thus, this fraction represents the contribution of mitochondrial oxidative phosphorylation to ATP production under the prevailing cultivation conditions. In transformed cells, cultivated in 25 mM glucose, OM addition resulted in a smaller reduction of the ATP levels as compared with normal cells that was significantly smaller at 1 mM glucose. Thus, these data show that in transformed cells the mitochondrial oxidative phosphorylation contributes only marginally to cellular ATP production, which is essentially contributed by glycolysis. 13 cAMP/PKA pathway alterations in transformed fibroblasts Direct determination of basal endogenous levels of cAMP along a time course of 72 h in cells grown at 25 and 1 mM glucose (Figures 2a and b) showed a time-dependent increase in cAMP levels in both cell lines. In transformed cells, at both 48 and 72 h, cAMP levels were higher than in normal cells (Figures 2a and b) . The addition of FSK (an activator of the adenylyl cyclases) increased, as expected, the level of cAMP, but such an increase was much larger in transformed cells as compared with normal ones (Figures 2a and b) .
Kinetic analysis of the PKA activity in cell extracts showed in transformed cells a constitutive (time 0 of the growth curve) depressed activity of the enzyme as compared with normal cells, which slightly increased in 48 h growth and was greatly enhanced by FSK addition to the cultivation medium (Figure 2d) . In normal cells, the PKA activity decreased significantly during cell growth and was further depressed by FSK (Figure 2c ). Direct immunochemical analysis revealed an increase in the cellular content of the catalytic subunit of PKA in 48 h of growth of normal and transformed cells, which in both type of cells was prevented by FSK addition (Figures 2e and f) . These findings indicate that the changes in the functional capacity of PKA, rather than being due to changes in the content of the enzyme, reflect altered PKA responsiveness to cellular activator(s)/inhibitor(s).
In order to evaluate the PKA activation state as a function of glucose availability and of oncogenic ras mutation, the extent of cAMP responsive element binding protein (CREB) phosphorylation was monitored in normal and transformed cells at both 25 and 1 mM glucose. In normal cells (Figure 3a) , as well in reverted cells (Supplementary Figures S2A and S2B) , phosphorylation of CREB significantly increased with the cultivation time, in particular at 25 mM glucose (Figure 3a) . On the contrary, in transformed cells no significant time-dependent increase in CREB phosphorylation occurred either at 25 or 1 mM glucose (Figure 3b ). FSK treatment resulted in a transient increase in CREB phosphorylation, which was larger and more persistent in transformed cells as compared with normal ones (Figures 3c and d) . Altogether, these findings show an altered regulation of the cAMP/PKA pathway in transformed cells.
Effects of FSK on cell growth, apoptosis and mitochondrial dynamics To gain an insight into the impact of the above-detected alterations of the cAMP/PKA pathway on mitochondrial dynamics and functions in K-ras-transformed cells, the effect of adenylyl cyclase activation by FSK was tested on cell growth, apoptosis, mitochondrial structure and functions of normal and transformed fibroblasts.
Proliferation of transformed cells grown at 1 mM glucose began to slow down at 48 h and under these conditions they started to die and undergo apoptosis more significantly and faster than normal cells (Figure 4 In order to investigate whether the survival of FSK-treated cells could be consequence of a different ability of transformed cells to transport and utilize glucose, glucose utilization as well as lactate production of both cell lines grown in 1 mM glucose condition Complex I activity, ROS production and ATP formation: effect of FSK In Figure 6 , the results of an analysis of the functional capacity of complex I and IV of the respiratory chain, ATP and ROS production in normal and transformed cells are presented at 72 h of growth in 1 mM glucose (48 h of FSK treatment). In transformed cells, the specific activity of complex I (NADH-ubiquinone oxidoreductase), depressed as compared with normal cells, was stimulated by FSK treatment (Figure 6b ), but it was unaffected in normal cells (Figure 6a) . No changes were observed in the specific activity of complex IV (cytochrome c oxidase) (Figure 6d ). Transformed cells as compared with normal ones showed a slight but significant increase in the respiratory activity with NAD-linked substrates, in particular in the uncoupled state, on FSK treatment (data not shown). No effect of FSK was observed on the respiratory activity with succinate as respiratory substrate (data not shown). The level of cellular ATP was increased by the presence of FSK in both cell lines (Figures 6e and f) . This increase was larger in transformed cells (Figures 6e and f) and was almost completely prevented by H89, especially in transformed cells as compared with normal cells (Figures 6e and f) . Notably, the FSK-dependent effects on complex I activity and ATP levels were also associated with a significant decrease in ROS levels in transformed cells (Figure 6h ). The addition to the cultivation medium of N-acetyl-cysteine (NAC), which decreased the ROS levels in both normal and transformed cells, partly sustained the growth of transformed cells but had no effect on normal cells (Supplementary Figure S6) . FSK-treated reverted cells did not show ATP levels increase (Supplementary Figure S2E) . Noteworthy, the positive effect on complex I by FSK treatment in transformed cells was observed also when they were grown in 25 mM glucose (Supplementary Figure S7) , pointing out to a general role of PKA as mitochondrial function regulator.
Mitochondrial dysfunctions in breast cancer MDA-MB-231 cells and FSK treatment effects MDA-MB-231 cells, harboring a K-ras oncogenic mutation, show a cellular metabolism similar to those observed in the mouse model of K-ras-dependent transformation. 54 Mitochondrial and metabolic characteristics of these human cancer cells were, thus, analyzed, both in untreated and FSK-treated conditions. MDA-MB-231 cells, grown at 1 mM glucose, 25 mM galactose (Figure 7a ) as well as at 5 mM fructose (Supplementary Figure S1C) showed a dramatic decrease in their proliferation capacity as compared with the cells grown at 25 mM glucose (Figure 7a ). Addition of OM in both glucose conditions did not cause any effect on total ATP levels (Figure 7b) , showing their dependence on glycolytic activity. FSK treatment of MDA-MB-231 cells grown at 1 mM glucose rescued their proliferation ability and decreased apoptosis (Figures 7c --e) . Similar results were obtained in other two human cancer cell lines harboring an oncogenic K-ras, namely MIA PaCa-2 (pancreatic) and A549 (lung). In fact, as shown in Supplementary Figure S8 , both were sensible to glucose deprivation, undergoing to cell death, and both were, in different extend, protected by FSK treatment. After 24 h of FSK treatment, MDA-MB-231 cells showed an increase in cellular cAMP levels (Figure 8a ), in complex I activity (Figure 8b ) and in ATP levels (Figure 8c and Supplementary Figure  S9A ) associated with a decrease in ROS levels (Figure 8d and Supplementary Figure S9B ) and an increase in mitochondrial interconnections (Figure 8f ). The increase in mitochondrial interconnections (Figure 8f , right panel) and ATP levels (data not shown) produced by FSK were prevented by H89 treatment, confirming the role of PKA in mitochondria regulation. Noteworthy, the FSK-dependent positive effects on complex I activity and mitochondrial fusion were observed also in MDA-MB-231 cells grown in 25 mM glucose (Supplementary Figure S10 ) as well as previously described for mouse transformed cells.
Mitochondrial fusion is induced also by short-term FSK treatment PKA-catalyzed phosphorylation of cellular proteins can result, in addition to long-term transcriptional effects as those mediated by CREB, in short-term regulation of mitochondrial respiration and 39, 50, 63 As reported for K-ras-transformed fibroblasts, no significant time-dependent CREB phosphorylation was observed in MDA-MB-231 cells grown at either 25 or 1 mM glucose (Figures 9a and b) . The addition of FSK, however, resulted in a transient increase in CREB phosphorylation, which after reaching a maximum at 1 h declined back to the initial value at 24 h of cultivation (Figures 9c and d) .
It has been reported that PKA-mediated phosphorylation of the pro-fission protein factor Drp1 inhibits fission with consequent increase in mitochondrial fusion. The results presented in Figure 10a show that FSK treatment of MDA-MB-231 cells induced phosphorylation of Drp1 between 1 and 4 h, which then disappeared at 24-h cultivation.
The effects of FSK and of the mitochondrial division inhibitor Mdivi-1, which prevents mitochondrial fission by inhibiting the Drp1 activity, were analyzed on mitochondrial dynamics in shorttime intervals. As shown in Figure 10b , treatment with FSK or Mdivi-1 of MDA-MB-231 cells grown at 1 mM glucose significantly increased mitochondrial interconnections as early as 1-h treatment. Analysis of ROS levels showed that the more interconnected mitochondria induced by FSK or Mdivi-1 were associated with a significant reduction of ROS levels (Figure 10c ).
DISCUSSION
Among the various cellular systems perturbed by oncogenic K-ras mutations in different cellular models, derangement in the cAMP/PKA signal pathway and its target systems has been reported. 24, 31, 64 The oncogenic K-ras-transformed cells analyzed in this study exhibit a strict dependence on high glucose concentration for growth. This shift from aerobic to fermentative ATP supply is shown, here, to be associated with a derangement in the cAMP/ PKA system, resulting in structural and functional alterations of mitochondria. K-ras-transformed mouse fibroblasts show a higher content of cAMP as compared with control fibroblasts. This and the finding that in these transformed cells, as well as in K-ras human breast cancer MDA-MB-231 cell line, adenyl cyclase activation by FSK results in a much larger increase in the cAMP level as compared with normal cells confirm an increased cyclase responsiveness to stimuli. The enhanced tendency of K-rastransformed fibroblasts to produce cAMP was, however, found to be associated to a reduced enzymatic activity of PKA and reduced phosphorylation of its substrate CREB, as compared with normal fibroblasts. Both these deficits were rescued by elevation of cAMP levels induced by FSK, which also prevented death of some human transformed K-ras cells like MDA-MB-231, MIA PaCa-2 and A549. Direct immunochemical determination of the catalytic subunit of PKA in transformed and normal mouse fibroblasts showed that the differences in the functional capacity of PKA between the two cell lines were not due to changes in the content of the enzyme but reflected altered responsiveness of PKA to cellular activators/inhibitors. The deregulation of the cAMP/PKA pathway can possibly represent a feed-back compensatory response of the cyclase to the depression of PKA activity.
The large increase in the cellular cAMP level induced by FSK and the resulting activation of PKA activity, with promotion of phosphorylation of PKA substrates like CREB and Drp1, prevented death of mouse and human ras-transformed cells in 1 mM glucoselimiting conditions. K-ras-transformed fibroblasts show depression of complex I activity and increase in ROS levels as compared with normal fibroblasts. As previously observed in various cellular pathophysiological conditions 37, 50 elevation of the cAMP level, induced by FSK in mouse and human ras-transformed cells, promoted the activity of complex I and decreased the ROS levels. Depression of complex I, which is by itself a major producer of ROS and is particularly vulnerable to oxidative stress, 65 can set up a 'vicious' cycle, detrimental for cell growth. In fact, decrease in ROS levels, affected by the addition of N-acetyl-cysteine, did promote the growth of ras-transformed cells.
It is worth noting that the activity of complex IV was not depressed in K-ras-transformed fibroblasts, neither was it affected by FSK addition. The activity of complex IV has been reported to be affected by phosphorylation of its subunits. 39 In the cell lines and the prevailing experimental conditions of the present work, the functional activity of complex IV is stable and unaffected by eventual phosphorylation (see also Piccoli et al.).
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The cAMP/PKA system is involved in regulation of the dynamics of mitochondrial fusion/fission. 40, 41, 66 In K-ras-transformed cells mitochondria were largely in a fragmented state. Elevation of the cAMP level by FSK largely reverted mitochondrial fragmentation, an effect that was prevented by the PKA inhibitor H89. Importantly, the positive effects of FSK treatment on the mitochondrial morphology and activity were observed both in high and low glucose availability implying that PKA pathway regulates mitochondrial function, at least in our experimental conditions, independently from glucose deprivation. It appears as the responsiveness to cAMP of the down-stream components of signal transduction is reduced in K-ras mutated cells, just opposite to the increased excitability of the cyclase. Altogether, these results show that the derangement of cAMP/PKA pathway in ras-transformed cells results in mitochondrial structure and respiration alterations with consequent cells dependence on glucose availability. The relationship between the dynamic equilibrium between fusion and fission of mitochondria and their respiratory activity is a matter of current investigation. 67 A set of G proteins has been found to regulate mitochondrial dynamics. 68 Among these the Drp1 protein promotes mitochondrial fission. Inactivation of Drp1, effected by its phosphorylation by PKA, can result in promotion of fusion and hence in protection from autophagy. 63 Immunochemical assays showed that in MDA-MB-231 cells, whose mitochondria were prevalently in the fragmented state, Drp1 was essentially in dephosphorylated state. Addition of FSK, which also in this case reverted mitochondrial fragmentation, promoted phosphorylation of Drp1. Other experiments showed that suppression of the activity of Drp-1 by its antagonist Mdivi-1 increased mitochondrial interconnection in MDA-MB-231 cells. Recent observations support the link between respiratory chain complexes activity, in particular complex I, and the mitochondrial fusion/fission process. 69, 70 Conversely, inhibition of complex I by rotenone results in mitochondrial fission. 71 In conclusion, this study shows a derangement of the cAMP/ PKA pathway in oncogenic K-ras-transformed cells, which results in impairment of mitochondrial fusion, associated with decreased activity of complex I, increased ROS production and apoptosis. These observations might serve to design new approaches in the development of anticancer drugs.
MATERIALS AND METHODS

Cell cultures
Mouse fibroblast NIH3T3 cells (ATCC, Manassas, VA, USA), K-rastransformed NIH3T3-derived cell line 226.4.1, 72 reverted NIH3T3, MDA-MB-231, MIA PaCa-2 and A549 cells were routinely cultured in Dulbecco's modified Eagle's medium containing 4 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin (complete medium), supplemented with 10% newborn calf serum (mouse cells) or 5 --10% fetal bovine serum (human cells). All reagents for media were purchased from Invitrogen (Carlsbad, CA, USA).
Cell treatments
For long-term studies, cells were plated at the density of 3000, 5000 (MIA PaCa-2) or 15 000 (A549) cells/cm 2 in complete growth medium. After 16 h, cells were washed twice with phosphate-buffered saline and incubated in growth medium (time 0) without glucose and sodium pyruvate (Invitrogen), supplemented with 25 or 1 mM glucose, 25 mM galactose or 5 mM fructose. Glucose, galactose and fructose were purchased from Sigma-Aldrich Inc. (St Louis, MO, USA). To stimulate the increase in cAMP levels, cells were daily treated with 10 mM forskolin (FSK) (Sigma-Aldrich) starting from 24 h after medium replacement. Cells were then collected for further analyses at 24, 48, 72, 96 and in some cases at 120 h of culture. Wherein indicated, to specifically inhibit PKA, H89 (N-[2-p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide dihydrochloride from Sigma-Aldrich) was used in combination with FSK. For short-term studies, cells were cultured as above described, except that they were treated at a single time point and then analyzed.
Intracellular ATP quantification
Intracellular ATP levels were measured using CellTiter Glo luciferinluciferase assay (Promega, Madison, WI, USA) as described in Gaglio et al.
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Wherein indicated, intracellular ATP levels were measured after cells treatment with 5 mM OM (Sigma-Aldrich).
Western blot analysis
For the analysis of total CREB, phospho-CREB Ser133, catalytic subunit of PKA, Drp1 and phospho-Drp1 Ser637 levels, 2 Â 10 5 cells were harvested and lysed in sodium dodecyl sulfate sample buffer 1 Â . Samples were then resolved by sodium dodecyl sulfate --polyacrylamide gel electrophoresis and transferred to nitrocellulose membrane, which was incubated cAMP cellular levels measurement and OXPHOS complex I and complex IV activities determination These assays were performed with little modifications as described in De Rasmo et al.
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Flow cytometric analyses Detection of cell viability and ROS levels was carried out through flow cytometric analyses using a FACScan flow cytometer (Becton-Dickinson, Franklin Lakes, NJ, USA) with CellQuest software (Becton-Dickinson). Cell viability was evaluated using the apoptosis assay kit (EXBIO Antibodies, Prague, Czech Republic) as specified in the manufacturer's datasheet. ROS levels were determined as described in Gaglio et al. 54 Analysis of flow cytometric data was carried out using the freely available WinMDI software. N-acetyl-L-cysteine was purchased from Sigma-Aldrich.
Mitochondrial morphology analysis
To study mitochondrial morphology, NIH3T3, K-ras-transformed NIH3T3 and MDA-MB-231 cells were transfected with pEYFP-Mito construct (6115-1, BD Biosciences) and stably transfected clones were isolated. Images of mitochondrial morphology were collected under a Nikon ECLIPSE 90i fluorescence microscope (Nikon, Tokyo, Japan) equipped with a b/w CCD camera (Hamamatsu-CoolSnap, Hamamatsu Corporation, Hamamatsu City, Japan) or using a laser scanning confocal microscope MRC-600 (Bio-Rad Microscience Division, Hemel Hempstead, UK) coupled to an Optiphot-2 Epi Fluor microscope (Nikon). Images were then visualized, processed and classified by using the freely available ImageJ software.
When indicated, to selectively induce mitochondrial interconnections 10 mM Mdivi-1 (3-(2,4-dichloro-5-methoxyphenyl)-2,3-dihydro-2 --thioxo-4(1H)-quinazolinone from Sigma-Aldrich) was used.
D-glucose and L-lactate measurement D-glucose and L-lactate levels in culture medium were determined as described in Chiaradonna et al.
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Glucose uptake Glucose uptake assay was performed using 2-NBDG (Invitrogen) fluorescent glucose analog. The cells were washed twice with phosphatebuffered saline, then their medium was replaced with a glucose-free medium supplemented with 60 mM 2-NBDG for 30 min at 37 1C. 
